'Thousands more' asking for mental health support
Daniel Harrison, community engagement lead at North Staffs Mind in Stoke-on-Trent, said the number of people it helped had increased from about 8,000 to 12,000 over the last three years.
He told BBC Radio Stoke this was due to a combination of more people needing support generally and fewer being afraid to ask for help.
"People are reaching out and asking for support a lot earlier than they used to," he said. "Especially if you rewind the clock 10 years ago."
Mr Harrison said the summer holidays often "disturbed" parents' and children's day-to-day routine, which can sometimes lead to issues around mental health.
"They are finding it tricky and I think we can all admit that life is a lot busier right now. It doesn't seem to slow down at any point," he added.
"Those extra stresses, they just build on to the anxiety that people face every day."
He said the charity offered a lot of support for young people, including through The Maccas Project created in memory of 19-year-old Thomas McCauley, who took his own life in 2012.
It also has a drop-in service for teenagers in Stoke-on-Trent and has counsellors in about 40 schools around Staffordshire.
Mr Harrison said: "I think it's hard for anyone, regardless of age, regardless of background, to talk about something that's very personal to them and something that makes them feel a lot more vulnerable."
But he said the conversation around mental health was "much more prevalent" in society and people felt more able to reach out for help than they used to.
Staffordshire County Council recently announced its Five Ways to Wellbeing campaign in a bid to tackle rising concerns over residents' mental health.
The authority said the county had seen a rise in emergency hospital admissions for self-harm as well as an above-average increase in new diagnoses of depression.
Follow BBC Stoke & Staffordshire on BBC Sounds, Facebook, X and Instagram.
Campaign launched to improve county's mental health
Bid to create 'first' mental health friendly town
'Peace pod' to help child mental health patients
Related internet links
North Staffs Mind
The Maccas Project
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
30 minutes ago
- Medscape
New First-Line Option for Advanced Bladder Cancer
The National Institute for Health and Care Excellence (NICE) has recommended the combination of enfortumab vedotin (Padcev, Astellas) with pembrolizumab (Keytruda, MSD) as a first-line option for adults with unresectable or metastatic urothelial cancer who are eligible for platinum-based chemotherapy. More than 1200 people in England are expected to benefit each year. Clinical experts described the combination therapy as a "step change" in bladder cancer management. Until now, treatment options for this patient group have seen little meaningful progress since the 1980s. Enfortumab vedotin is an antibody-drug conjugate consisting of an antibody targeting Nectin-4, a protein highly expressed in urothelial carcinoma cells. After binding, it causes the cells to release monomethyl auristatin E, resulting in cell death. Pembrolizumab, its combination partner, is a PD-1 inhibitor. High Disease Burden Urothelial cancer accounts for around 90% of bladder cancers, affecting more than 18,000 people annually in England. Prognosis is poor, with only 10% of patients with stage 4 disease surviving for 5 years or more. Current standard treatments include platinum-based chemotherapy ( cisplatin or carboplatin with gemcitabine), followed by avelumab maintenance therapy if the cancer has not progressed. However, only about 12% of patients see improvement with chemotherapy, underscoring the need for better options. Patient experts described living with metastatic urothelial cancer as "intensely challenging and emotionally exhausting', affecting work, travel, and physical activity. Action Bladder Cancer UK called the announcement a 'very welcome, and significant, step forward for this hard-to-treat cancer'. Clinical Evidence The recommendation in final draft guidance was supported by results from the phase 3 EV-302 trial, which enrolled 886 adults with untreated, unresectable, locally advanced, or metastatic urothelial cancer. Participants were randomly assigned in a 1:1 ratio to receive either enfortumab vedotin–pembrolizumab or standard chemotherapy. Enfortumab vedotin–pembrolizumab nearly doubled the median time to disease progression or death to 12.5 months, compared with 6.3 months for chemotherapy. Median overall survival was also improved, at 33.8 months versus 15.9 months with chemotherapy. Helen Knight, director of medicines evaluation at NICE, said the drug combination is 'highly promising and effective,' adding that these clinical trial results highlight the 'tremendous difference' it could make to the length and quality of people's lives. Cost and NHS Access Enfortumab vedotin is listed at £578 per 20 mg vial or £867 per 30 mg vial. Pembrolizumab costs £2630 per 100 mg vial, excluding VAT. The drugs will be supplied through confidential commercial arrangements with the NHS. NICE's appraisal committee applied a severity modifier, reflecting the high disease burden, and concluded that the therapy met acceptable cost-effectiveness thresholds. The treatment will be available immediately across the NHS in England, with funding required within 90 days of final publication of the guidance.
Medscape
an hour ago
- Medscape
Safety Watchdog Flags Ongoing Maternity Risks
The Health Services Safety Investigations Body (HSSIB) has released a preliminary report on maternity and neonatal safety in England. The exploratory review, carried out in spring 2025, highlighted concerns across the entire maternity and neonatal care pathway despite years of initiatives aimed at improvement. The review comes after a series of high-profile scandals, including at Shrewsbury and Telford Hospital NHS Trust and Nottingham University Hospitals NHS Trust. The Shrewsbury inquiry, led by senior midwife Donna Ockenden, found that approximately 201 babies and nine mothers might have survived if they had received better care. The Nottingham review — also led by Ockenden — remains ongoing. Safety Concerns and Baby Deaths The HSSIB's latest report indicates that safety concerns persist. Between October 2023 and June 2025, the board received 35 reports of safety concerns in maternity or neonatal services. These accounted for about 10% of all safety concerns received during that period. All cases involved "very serious harm", including 10 baby deaths. Sixteen incidents occurred during labour, and 12 during the neonatal period. Most reports came from women or family members, although some were submitted by healthcare staff. Full Investigation Paused The board had begun a scoping exercise to assess the need for a full investigation. However, the work was paused in June after the Secretary of State for Health and Social Care announced a national investigation into maternity and neonatal services, due to report in December 2025. Health Secretary Wes Streeting said that multiple reviews into local trusts had found "similar failings in compassionate care" after maternity service failures "that should never have happened". He acknowledged "systemic" failings dating back more than 15 years and said families had been "gaslit" in their search for answers about their babies' deaths. Although pausing its work, the HSSIB published its exploratory findings to support the national investigation. These were based on the 35 recent safety reports, meetings with 17 stakeholders, and a 2021 report by its precursor organisation, the Healthcare Safety Investigation Branch. 'Compounded Harms' to Families The report identified 11 key themes. Progress had been made in maternity and neonatal outcomes, staffing levels, and governance, but disparities in care and outcomes persisted, partly due to health inequalities. The HSSIB found that maternity and neonatal systems were overly complex, with inconsistent collaboration and poor information sharing. Local governance often operated in isolation, and services struggled to identify and respond to clinical risks or to learn from the harms that happened to women and babies during pregnancy, labour, and birth. "Patients experience compounded harm due to issues within the wider healthcare system," the report concluded. It highlighted that local investigations, complaints processes, and legal proceedings such as inquests often caused additional harm. "Staff and trusts can lose sight of compassion during this process," it said. Four Areas for Further Review The HSSIB recommended four areas for potential further investigation: National structures responsible for providing direction and oversight for maternity services. Local governance and its relationship to national bodies. Standards and approaches of local investigations when things go wrong. Education, training, and professional standards for clinicians. Staff Experience Cumulative Stress The report said that maternity and neonatal staff also experienced cumulative stress and harm. It raised concerns about the standards set in undergraduate and postgraduate education, and whether these could be met in practice, noting that too many recommendations were being made, with limited implementation. The HSSIB warned that multiple, high-profile maternity investigations and inquiries had eroded public confidence in maternity services. Some women were avoiding hospitals that had been the focus of national investigations, undermining recruitment and damaging staff morale. The report cited instances of midwives receiving death threats or being berated for working in 'failing' services. Stakeholders had told the HSSIB that clinicians had also become more risk-averse for fear of blame, a defensive approach that "drives the behaviour that compounds the harm women and families experience".
Yahoo
2 hours ago
- Yahoo
Backpack Healthcare Secures $3 Million Contract to Expand Mental Health Services to 150,000+ Students with Scalable Hybrid Model
WASHINGTON, Aug. 21, 2025 /PRNewswire/ -- In response to impending Medicaid policy shifts, Backpack Healthcare has been awarded a $3 million contract, funded by the Maryland Community Health Resources Commission (CHRC) through the Maryland Consortium on Coordinated Community Supports, to provide comprehensive mental health services to over 150,000 students across several school districts. This funding supports Backpack's mission to deliver accessible, scalable mental health support at a critical time. The hybrid model, combining in-person and telehealth options, positions Backpack as a thought leader in adapting to changes in behavioral health policy and offers a scalable solution for school systems nationwide. The contract will provide critical support through individual and group therapy, peer coaching, caregiver wellness workshops, and substance use prevention groups in schools across both counties. This initiative is part of the broader Blueprint for Maryland's Future, which addresses the growing mental health needs of students and offers a model for other districts to follow in preparing for future Medicaid policy adjustments. "The Consortium is pleased to continue our partnership with Backpack Healthcare to support the mental health and wellbeing of Maryland students," said Consortium Chair David Rudolph. "We look forward to working with Backpack as they expand their services through this grant." This agreement is part of a broader effort to help schools adapt to funding shifts and strengthen behavioral health services. Backpack Healthcare will serve over 150,000 students in Baltimore and Howard County, improving access to essential mental health services. In addition to the contract, Backpack Healthcare has released a White Paper titled "Meeting the Moment: How School-Based Mental Health Services Improve Access and Outcomes," providing evidence-based insights into the effectiveness of these services. "We've seen the impact school-based mental health services can have in Howard County, and we're excited to expand that success with Baltimore County," said Jay Taylor, Chief Growth Officer at Backpack Healthcare. "The need for accessible, stigma-free support has never been greater, and we're proud to help meet it. Together, we have a unique opportunity to reach more students, remove barriers to care, and ensure every young person has the support they need to thrive academically, emotionally, and socially." This expansion not only serves existing districts but also aims to attract new partnerships with other school systems facing similar challenges. As districts prepare for Medicaid policy changes, Backpack Healthcare is ready to meet these needs with a proven, cost-effective model. For more information about Backpack Healthcare's services, including how to implement these solutions in your district, or to download the white paper, visit or contact partners@ About Backpack HealthcareBackpack Healthcare is a leading provider of innovative mental health services, focused on supporting children, teens, and families. By leveraging school-based programs and technology, Backpack Healthcare is making mental health care more accessible and effective, helping students thrive academically and emotionally. About the Maryland Community Health Resources Commission: The grant was awarded by the Maryland Community Health Resources Commission (CHRC), established by the Maryland General Assembly in 2005 to expand access to health services in underserved communities. Since its inception, the CHRC has awarded over 980 grants totaling over $392 million in funding, supporting programs in every jurisdiction of the State. These programs have collectively served more than 770,000 Marylanders. More information about the CHRC can be found at this URL: About the Maryland Consortium on Coordinated Community Supports: The Maryland Consortium on Coordinated Community Supports (Consortium) was established by the Maryland General Assembly as part of the Blueprint for Maryland's Future to create a statewide framework to increase access to coordinated non-stigmatized, comprehensive behavioral health services statewide. The CHRC is the fiscal agent and provides staff support for the Consortium. More information about the Consortium can be found at this url: Media Contact:marketing@ View original content: SOURCE Backpack Healthcare (Formerly Youme Healthcare) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
